Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Factors associated with SARS-CoV-2 among persons living with HIV in Zambia: Analysis of three concurrent SARS-CoV-2 prevalence surveys conducted in July 2020 in six districts of Zambia

View ORCID ProfileStephen Longa Chanda, View ORCID ProfileCephas Sialubanje, View ORCID ProfileMukumbuta Nawa, Nyambe Sinyange, Warren Malambo, View ORCID ProfileJames Zulu, Dabwitso Banda, View ORCID ProfilePaul Zulu, Jonas Hines
doi: https://doi.org/10.1101/2023.10.10.23296849
Stephen Longa Chanda
1Zambia National Public Health Institute, Surveillance and Disease Intelligence Cluster, Lusaka Zambia
2School of Public Health, Department of Environmental and Public Health, Levy Mwanawasa Medical University, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen Longa Chanda
  • For correspondence: longachandadoc88{at}gmail.com
Cephas Sialubanje
2School of Public Health, Department of Environmental and Public Health, Levy Mwanawasa Medical University, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cephas Sialubanje
Mukumbuta Nawa
2School of Public Health, Department of Environmental and Public Health, Levy Mwanawasa Medical University, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mukumbuta Nawa
Nyambe Sinyange
1Zambia National Public Health Institute, Surveillance and Disease Intelligence Cluster, Lusaka Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Warren Malambo
3United States Centers for Disease Control and Prevention, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Zulu
1Zambia National Public Health Institute, Surveillance and Disease Intelligence Cluster, Lusaka Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James Zulu
Dabwitso Banda
1Zambia National Public Health Institute, Surveillance and Disease Intelligence Cluster, Lusaka Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Zulu
1Zambia National Public Health Institute, Surveillance and Disease Intelligence Cluster, Lusaka Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Zulu
Jonas Hines
3United States Centers for Disease Control and Prevention, Lusaka, Zambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

People living with HIV (PLHIV) are a unique population because of their altered immune systems and taking antiretroviral therapy (ART) that may modify risk of SARS-CoV-2. Evidence from sub-Saharan African countries suggests that, despite not having higher SARS-CoV-2 infection prevalence than HIV-negative persons, PLHIV suffer worse COVID-19 outcomes. We assessed the prevalence of SARS-COV-2 infection by HIV status in Zambia in July 2020.

We analyzed data from three different concurrent SARS-CoV-2 prevalence surveys (household, outpatient-department, and health-worker) conducted in six districts of Zambia in July 2020. Information on demographics and medical history was collected. Nasopharyngeal swabs were used to screen for SARS-CoV-2 RNA using polymerase-chain-reaction (PCR) and blood specimens were screened for SARS-CoV-2 virus-specific antibodies using an enzyme-linked-immunosorbent-assay (ELISA). Test-specific SARS-CoV-2 prevalence was calculated. Multilevel logistic regression models were used to measure test-specific adjusted odd ratios (aORs) of SARS-CoV-2 positivity by HIV status, controlling for demographic and medical history.

We analysed the outcomes of the two different tests separately. Among 7,092 participants, 4,717 (66.5%) consented to blood-draw and 4,642 (65.5%) consented to nasopharyngeal swab. Overall SARS-CoV-2 positivity was 9.4% by PCR and 3.8% by ELISA. SARS-CoV-2 prevalence detected by PCR was higher among PLHIV than HIV-negative respondents (12.4% vs 9.1%, respectively, OR: 1.4, 95% confidence intervals [CI]: 1.0-1.9) and lower by ELISA (1.9% vs 3.9%, respectively, OR: 0.5, 95%CI: 0.2-0.9). Among PLHIV, not being on ART was an independent predictor of SARS-CoV-2 PCR positivity (aOR: 5.24,95% CI: 1.19-22.22) but did not have a significant effect on ELISA results.

During the first COVID-19 wave in Zambia, PLHIV were more likely to be acutely infected with SARS-CoV-2 but less likely to be seropositive than participants without HIV. Intervention programs could focus on early access to COVID-19 vaccinations, testing and ART might reduce COVID-19 morbidity among PLHIV.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the United States Centers for Disease Control and Prevention, Zambia. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the US Centers for Disease Control and Prevention or the US Department of Health and Human Services

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical waiver was obtained from ERES converge (Ref.No.2021-November-010) and authority to conduct this investigation in Zambia was obtained from National Research Authority (Ref.No.NHRA 0000008/31/10/2022).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Data Availability

The data that support the findings of this study are available from the Ministry of Health of the Government of Zambia, but restrictions apply to the availability of these data, which were used under permission for the current study, and so are not publicly available. However, the data are available from the authors upon reasonable request and with permission of the Permanent Secretary of the Ministry of Health.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted October 12, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Factors associated with SARS-CoV-2 among persons living with HIV in Zambia: Analysis of three concurrent SARS-CoV-2 prevalence surveys conducted in July 2020 in six districts of Zambia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Factors associated with SARS-CoV-2 among persons living with HIV in Zambia: Analysis of three concurrent SARS-CoV-2 prevalence surveys conducted in July 2020 in six districts of Zambia
Stephen Longa Chanda, Cephas Sialubanje, Mukumbuta Nawa, Nyambe Sinyange, Warren Malambo, James Zulu, Dabwitso Banda, Paul Zulu, Jonas Hines
medRxiv 2023.10.10.23296849; doi: https://doi.org/10.1101/2023.10.10.23296849
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Factors associated with SARS-CoV-2 among persons living with HIV in Zambia: Analysis of three concurrent SARS-CoV-2 prevalence surveys conducted in July 2020 in six districts of Zambia
Stephen Longa Chanda, Cephas Sialubanje, Mukumbuta Nawa, Nyambe Sinyange, Warren Malambo, James Zulu, Dabwitso Banda, Paul Zulu, Jonas Hines
medRxiv 2023.10.10.23296849; doi: https://doi.org/10.1101/2023.10.10.23296849

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)